BioCentury
ARTICLE | Company News

Aclara, ViroLogic deal

December 20, 2004 8:00 AM UTC

The companies completed their previously announced merger to create a personalized medicine company focused on cancer and infectious diseases. Each outstanding share of ACLA was exchanged for 1.7 VLGC...